BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/18/2025 7:53:25 AM | Browse: 49 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 105604
Country China
Category Pediatrics
Manuscript Type Basic Study
Article Title Combined detection of P53, Ki67, P504S, and IMP3: Diagnostic implications for gastric cancer and precursor lesions
Manuscript Source Unsolicited Manuscript
All Author List Lan-Fang Miao, Yuan-Yuan Sun, Xian-Juan Du, Nan Xu, Jing-Wei Shen, Hui Hua, Mei Guo, Hai-Jun Yang, Jun-Kuo Li and Lei Zhu
Funding Agency and Grant Number
Funding Agency Grant Number
The Science and Technology Research Project of Anyang 2022C01SF074
Corresponding Author Lan-Fang Miao, Associate Chief Physician, Department of Pathology, Anyang Tumor Hospital, No. 1 Huanbin Road, Anyang 455000, Henan Province, China. lanfang_miao@163.com
Key Words Gastric mucosal biopsy; Precursor lesions; IMP3; P504S; P53; Ki67
Core Tip The combined detection of P504S and Ki67 for low-grade dysplasia (LGD), and IMP3 and P53 for high-grade dysplasia (HGD) and adenocarcinoma (AC), enhances diagnostic sensitivity, aiding in the differentiation of gastric cancer and its precancerous lesions, thereby improving early cancer diagnosis. Immunohistochemical markers P504S, Ki67, IMP3, and P53 are valuable in distinguishing gastric lesions, including atypical hyperplasia (AH), LGD, HGD, and AC. P504S is predominantly expressed in LGD and shows a correlation with the Ki67 “polarity” expression pattern, while IMP3 is highly expressed in HGD/AC and correlates with the P53 mutation pattern. The combined detection of P504S with Ki67 and IMP3 with P53 significantly enhances the diagnostic sensitivity of LGD and HGD/AC, aiding in the early detection of gastric cancer and its precancerous lesions. This approach can improve the accuracy of pathological diagnoses, thereby facilitating timely intervention.
Citation <p>Miao LF, Sun YY, Du XJ, Xu N, Shen JW, Hua H, Guo M, Yang HJ, Li JK, Zhu L. Combined detection of P53, Ki67, P504S, and IMP3: Diagnostic implications for gastric cancer and precursor lesions. <i>World J Gastrointest Oncol</i> 2025; 17(5): 105604</p>
Received
2025-01-30 12:49
Peer-Review Started
2025-01-30 12:50
To Make the First Decision
Return for Revision
2025-02-26 07:42
Revised
2025-03-11 03:38
Second Decision
2025-04-18 02:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-04-18 07:53
Articles in Press
2025-04-18 07:53
Publication Fee Transferred
2025-03-12 14:56
Edit the Manuscript by Language Editor
2025-04-20 14:41
Typeset the Manuscript
2025-04-24 00:51
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com